The global AI-driven Peptide Drug Discovery Platform market is projected to grow from US$ 715 million in 2024 to US$ 1324 million by 2031, at a CAGR of 9.2% (2025-2031), driven by critical product segments and diverse end‑use applications.

AI-driven Peptide Drug Discovery Platform Market

AI-driven Peptide Drug Discovery Platforms are tools that use artificial intelligence (AI) technology to accelerate and optimize the discovery and development process of peptide drugs. These platforms typically combine computational biology, machine learning, deep learning and other technologies to improve the efficiency of identifying, designing, optimizing and validating drug candidate molecules.

The global AI-driven peptide drug R&D market is in a period of rapid growth, with the core driving force coming from the high failure rate of traditional peptide R&D (over 90% elimination rate in the preclinical stage) and the significant advantages of AI technology in reducing costs and increasing efficiency (shortening the early R&D cycle by 50%). North America occupies a dominant position (about 48% market share in 2023), mainly due to the concentration of leading companies such as Insilico Medicine and Schrödinger and active biopharmaceutical venture capital; the Asia-Pacific region has the fastest growth rate (CAGR of 29%), thanks to China's "14th Five-Year Plan for Bioeconomic Development" policy support for AI pharmaceuticals and technological breakthroughs by local companies such as Tai Technology. In the sub-sectors, tumor treatment (PDC drug development) and anti-infective drugs (antimicrobial peptide optimization) account for more than 60% of the market share, while metabolic diseases and neurological diseases have become emerging growth poles due to breakthroughs in GLP-1 analogs and blood-brain barrier penetration technology. The challenges faced by the industry are the low clinical conversion rate (only 7% of AI-designed drug candidates enter Phase II clinical trials) and data barriers (data closure of pharmaceutical companies limits model training), but the deepening cooperation between multinational pharmaceutical companies and AI platforms (such as Pfizer and Cyclica jointly developing peptide vaccines) is promoting the openness of the ecosystem. In the future, peptide-nucleic acid conjugates (PepRNA) and AI-driven fully automated laboratories (such as the Strateos cloud-based robotics platform) may reshape the industry's competitive landscape.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global AI-driven Peptide Drug Discovery Platform market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of AI-driven Peptide Drug Discovery Platform Market Report

Report Metric	Details
Report Name	AI-driven Peptide Drug Discovery Platform Market
Accounted market size in 2024	US$ 715 million
Forecasted market size in 2031	US$ 1324 million
CAGR	9.2%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Design and Generation Platform Screening and Optimization Platform Data-driven Platform Others
Segment by Application	Scientific Research Pharmaceuticals
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI, Insilico Medicine, Schrödinger, BenevolentAI, Evotec, PeptiFinder, Xtalpi, Sun Novo, Zonsen Peplib Biotech, Tide Tron Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the AI-driven Peptide Drug Discovery Platform study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is AI-driven Peptide Drug Discovery Platform Market growing?

Ans: The AI-driven Peptide Drug Discovery Platform Market witnessing a CAGR of 9.2% during the forecast period 2025-2031.

What is the AI-driven Peptide Drug Discovery Platform Market size in 2031?

Ans: The AI-driven Peptide Drug Discovery Platform Market size in 2031 will be US$ 1324 million.

Who are the main players in the AI-driven Peptide Drug Discovery Platform Market report?

Ans: The main players in the AI-driven Peptide Drug Discovery Platform Market are Peptilogics, Pepticom Ltd, Menten AI, GUBRA, Creative Peptides, Exscalate, Generate Biomedicines, Receptor.AI, Insilico Medicine, Schrödinger, BenevolentAI, Evotec, PeptiFinder, Xtalpi, Sun Novo, Zonsen Peplib Biotech, Tide Tron Biotech

What are the Application segmentation covered in the AI-driven Peptide Drug Discovery Platform Market report?

Ans: The Applications covered in the AI-driven Peptide Drug Discovery Platform Market report are Scientific Research, Pharmaceuticals

What are the Type segmentation covered in the AI-driven Peptide Drug Discovery Platform Market report?

Ans: The Types covered in the AI-driven Peptide Drug Discovery Platform Market report are Design and Generation Platform, Screening and Optimization Platform, Data-driven Platform, Others

1 Study Coverage

1.1 Introduction to AI-driven Peptide Drug Discovery Platform: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Design and Generation Platform

1.2.3 Screening and Optimization Platform

1.2.4 Data-driven Platform

1.2.5 Others

1.3 Market Segmentation by Application

1.3.1 Global AI-driven Peptide Drug Discovery Platform Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Scientific Research

1.3.3 Pharmaceuticals

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global AI-driven Peptide Drug Discovery Platform Revenue Estimates and Forecasts 2020-2031

2.2 Global AI-driven Peptide Drug Discovery Platform Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

3 Competition by Players

3.1 Global AI-driven Peptide Drug Discovery Platform Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global AI-driven Peptide Drug Discovery Platform Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Design and Generation Platform Market Size by Players

3.3.2 Screening and Optimization Platform Market Size by Players

3.3.3 Data-driven Platform Market Size by Players

3.3.4 Others Market Size by Players

3.4 Global AI-driven Peptide Drug Discovery Platform Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global AI-driven Peptide Drug Discovery Platform Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global AI-driven Peptide Drug Discovery Platform Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)

6.4 North America AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America AI-driven Peptide Drug Discovery Platform Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)

7.4 Europe AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe AI-driven Peptide Drug Discovery Platform Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)

8.4 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific AI-driven Peptide Drug Discovery Platform Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)

9.4 Central and South America AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America AI-driven Peptide Drug Discovery Platform Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size by Type (2020-2031)

10.4 Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa AI-driven Peptide Drug Discovery Platform Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 Peptilogics

11.1.1 Peptilogics Corporation Information

11.1.2 Peptilogics Business Overview

11.1.3 Peptilogics AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.1.4 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.1.5 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024

11.1.6 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024

11.1.7 Peptilogics AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024

11.1.8 Peptilogics AI-driven Peptide Drug Discovery Platform SWOT Analysis

11.1.9 Peptilogics Recent Developments

11.2 Pepticom Ltd

11.2.1 Pepticom Ltd Corporation Information

11.2.2 Pepticom Ltd Business Overview

11.2.3 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.2.4 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.2.5 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024

11.2.6 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024

11.2.7 Pepticom Ltd AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024

11.2.8 Pepticom Ltd AI-driven Peptide Drug Discovery Platform SWOT Analysis

11.2.9 Pepticom Ltd Recent Developments

11.3 Menten AI

11.3.1 Menten AI Corporation Information

11.3.2 Menten AI Business Overview

11.3.3 Menten AI AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.3.4 Menten AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.3.5 Menten AI AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024

11.3.6 Menten AI AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024

11.3.7 Menten AI AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024

11.3.8 Menten AI AI-driven Peptide Drug Discovery Platform SWOT Analysis

11.3.9 Menten AI Recent Developments

11.4 GUBRA

11.4.1 GUBRA Corporation Information

11.4.2 GUBRA Business Overview

11.4.3 GUBRA AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.4.4 GUBRA AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.4.5 GUBRA AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024

11.4.6 GUBRA AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024

11.4.7 GUBRA AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024

11.4.8 GUBRA AI-driven Peptide Drug Discovery Platform SWOT Analysis

11.4.9 GUBRA Recent Developments

11.5 Creative Peptides

11.5.1 Creative Peptides Corporation Information

11.5.2 Creative Peptides Business Overview

11.5.3 Creative Peptides AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.5.4 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.5.5 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue by Product in 2024

11.5.6 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue by Application in 2024

11.5.7 Creative Peptides AI-driven Peptide Drug Discovery Platform Revenue by Geographic Area in 2024

11.5.8 Creative Peptides AI-driven Peptide Drug Discovery Platform SWOT Analysis

11.5.9 Creative Peptides Recent Developments

11.6 Exscalate

11.6.1 Exscalate Corporation Information

11.6.2 Exscalate Business Overview

11.6.3 Exscalate AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.6.4 Exscalate AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.6.5 Exscalate Recent Developments

11.7 Generate Biomedicines

11.7.1 Generate Biomedicines Corporation Information

11.7.2 Generate Biomedicines Business Overview

11.7.3 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.7.4 Generate Biomedicines AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.7.5 Generate Biomedicines Recent Developments

11.8 Receptor.AI

11.8.1 Receptor.AI Corporation Information

11.8.2 Receptor.AI Business Overview

11.8.3 Receptor.AI AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.8.4 Receptor.AI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.8.5 Receptor.AI Recent Developments

11.9 Insilico Medicine

11.9.1 Insilico Medicine Corporation Information

11.9.2 Insilico Medicine Business Overview

11.9.3 Insilico Medicine AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.9.4 Insilico Medicine AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.9.5 Insilico Medicine Recent Developments

11.10 Schrödinger

11.10.1 Schrödinger Corporation Information

11.10.2 Schrödinger Business Overview

11.10.3 Schrödinger AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.10.4 Schrödinger AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

11.11 BenevolentAI

11.11.1 BenevolentAI Corporation Information

11.11.2 BenevolentAI Business Overview

11.11.3 BenevolentAI AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.11.4 BenevolentAI AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.11.5 BenevolentAI Recent Developments

11.12 Evotec

11.12.1 Evotec Corporation Information

11.12.2 Evotec Business Overview

11.12.3 Evotec AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.12.4 Evotec AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.12.5 Evotec Recent Developments

11.13 PeptiFinder

11.13.1 PeptiFinder Corporation Information

11.13.2 PeptiFinder Business Overview

11.13.3 PeptiFinder AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.13.4 PeptiFinder AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.13.5 PeptiFinder Recent Developments

11.14 Xtalpi

11.14.1 Xtalpi Corporation Information

11.14.2 Xtalpi Business Overview

11.14.3 Xtalpi AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.14.4 Xtalpi AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.14.5 Xtalpi Recent Developments

11.15 Sun Novo

11.15.1 Sun Novo Corporation Information

11.15.2 Sun Novo Business Overview

11.15.3 Sun Novo AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.15.4 Sun Novo AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.15.5 Sun Novo Recent Developments

11.16 Zonsen Peplib Biotech

11.16.1 Zonsen Peplib Biotech Corporation Information

11.16.2 Zonsen Peplib Biotech Business Overview

11.16.3 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.16.4 Zonsen Peplib Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.16.5 Zonsen Peplib Biotech Recent Developments

11.17 Tide Tron Biotech

11.17.1 Tide Tron Biotech Corporation Information

11.17.2 Tide Tron Biotech Business Overview

11.17.3 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Product Features and Attributes

11.17.4 Tide Tron Biotech AI-driven Peptide Drug Discovery Platform Revenue and Gross Margin (2020-2025)

11.17.5 Tide Tron Biotech Recent Developments

12 AI-driven Peptide Drug Discovery PlatformIndustry Chain Analysis

12.1 AI-driven Peptide Drug Discovery Platform Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 AI-driven Peptide Drug Discovery Platform Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global AI-driven Peptide Drug Discovery Platform Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

Generate:Biomedicines

Zonsen PepLib Biotech

List of Tables

Table 1. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global AI-driven Peptide Drug Discovery Platform Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global AI-driven Peptide Drug Discovery Platform Revenue by Region (2026-2031) & (US$ Million)

Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 7. Global AI-driven Peptide Drug Discovery Platform Revenue by Players (2020-2025) & (US$ Million)

Table 8. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Players (2020-2025)

Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 10. Global AI-driven Peptide Drug Discovery Platform by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Peptide Drug Discovery Platform as of 2024)

Table 11. Global AI-driven Peptide Drug Discovery Platform Average Gross Margin (%) by Player (2020 VS 2024)

Table 12. Global AI-driven Peptide Drug Discovery Platform Companies Headquarters

Table 13. Global AI-driven Peptide Drug Discovery Platform Market Concentration Ratio (CR5 and HHI)

Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 16. Global AI-driven Peptide Drug Discovery Platform Revenue by Type (2020-2025) & (US$ Million)

Table 17. Global AI-driven Peptide Drug Discovery Platform Revenue by Type (2026-2031) & (US$ Million)

Table 18. Key Product Attributes and Differentiation

Table 19. Global AI-driven Peptide Drug Discovery Platform Revenue by Application (2020-2025) & (US$ Million)

Table 20. Global AI-driven Peptide Drug Discovery Platform Revenue by Application (2026-2031) & (US$ Million)

Table 21. AI-driven Peptide Drug Discovery Platform High-Growth Sectors Demand CAGR (2024-2031)

Table 22. Top Customers by Region

Table 23. Top Customers by Application

Table 24. North America AI-driven Peptide Drug Discovery Platform Growth Accelerators and Market Barriers

Table 25. North America AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 26. Europe AI-driven Peptide Drug Discovery Platform Growth Accelerators and Market Barriers

Table 27. Europe AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 28. Asia-Pacific AI-driven Peptide Drug Discovery Platform Growth Accelerators and Market Barriers

Table 29. Asia-Pacific AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 30. Central and South America AI-driven Peptide Drug Discovery Platform Investment Opportunities and Key Challenges

Table 31. Central and South America AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 32. Middle East and Africa AI-driven Peptide Drug Discovery Platform Investment Opportunities and Key Challenges

Table 33. Middle East and Africa AI-driven Peptide Drug Discovery Platform Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 34. Peptilogics Corporation Information

Table 35. Peptilogics Description and Major Businesses

Table 36. Peptilogics Product Features and Attributes

Table 37. Peptilogics Revenue (US$ Million) and Gross Margin (2020-2025)

Table 38. Peptilogics Revenue Proportion by Product in 2024

Table 39. Peptilogics Revenue Proportion by Application in 2024

Table 40. Peptilogics Revenue Proportion by Geographic Area in 2024

Table 41. Peptilogics AI-driven Peptide Drug Discovery Platform SWOT Analysis

Table 42. Peptilogics Recent Developments

Table 43. Pepticom Ltd Corporation Information

Table 44. Pepticom Ltd Description and Major Businesses

Table 45. Pepticom Ltd Product Features and Attributes

Table 46. Pepticom Ltd Revenue (US$ Million) and Gross Margin (2020-2025)

Table 47. Pepticom Ltd Revenue Proportion by Product in 2024

Table 48. Pepticom Ltd Revenue Proportion by Application in 2024

Table 49. Pepticom Ltd Revenue Proportion by Geographic Area in 2024

Table 50. Pepticom Ltd AI-driven Peptide Drug Discovery Platform SWOT Analysis

Table 51. Pepticom Ltd Recent Developments

Table 52. Menten AI Corporation Information

Table 53. Menten AI Description and Major Businesses

Table 54. Menten AI Product Features and Attributes

Table 55. Menten AI Revenue (US$ Million) and Gross Margin (2020-2025)

Table 56. Menten AI Revenue Proportion by Product in 2024

Table 57. Menten AI Revenue Proportion by Application in 2024

Table 58. Menten AI Revenue Proportion by Geographic Area in 2024

Table 59. Menten AI AI-driven Peptide Drug Discovery Platform SWOT Analysis

Table 60. Menten AI Recent Developments

Table 61. GUBRA Corporation Information

Table 62. GUBRA Description and Major Businesses

Table 63. GUBRA Product Features and Attributes

Table 64. GUBRA Revenue (US$ Million) and Gross Margin (2020-2025)

Table 65. GUBRA Revenue Proportion by Product in 2024

Table 66. GUBRA Revenue Proportion by Application in 2024

Table 67. GUBRA Revenue Proportion by Geographic Area in 2024

Table 68. GUBRA AI-driven Peptide Drug Discovery Platform SWOT Analysis

Table 69. GUBRA Recent Developments

Table 70. Creative Peptides Corporation Information

Table 71. Creative Peptides Description and Major Businesses

Table 72. Creative Peptides Product Features and Attributes

Table 73. Creative Peptides Revenue (US$ Million) and Gross Margin (2020-2025)

Table 74. Creative Peptides Revenue Proportion by Product in 2024

Table 75. Creative Peptides Revenue Proportion by Application in 2024

Table 76. Creative Peptides Revenue Proportion by Geographic Area in 2024

Table 77. Creative Peptides AI-driven Peptide Drug Discovery Platform SWOT Analysis

Table 78. Creative Peptides Recent Developments

Table 79. Exscalate Corporation Information

Table 80. Exscalate Description and Major Businesses

Table 81. Exscalate Product Features and Attributes

Table 82. Exscalate Revenue (US$ Million) and Gross Margin (2020-2025)

Table 83. Exscalate Recent Developments

Table 84. Generate Biomedicines Corporation Information

Table 85. Generate Biomedicines Description and Major Businesses

Table 86. Generate Biomedicines Product Features and Attributes

Table 87. Generate Biomedicines Revenue (US$ Million) and Gross Margin (2020-2025)

Table 88. Generate Biomedicines Recent Developments

Table 89. Receptor.AI Corporation Information

Table 90. Receptor.AI Description and Major Businesses

Table 91. Receptor.AI Product Features and Attributes

Table 92. Receptor.AI Revenue (US$ Million) and Gross Margin (2020-2025)

Table 93. Receptor.AI Recent Developments

Table 94. Insilico Medicine Corporation Information

Table 95. Insilico Medicine Description and Major Businesses

Table 96. Insilico Medicine Product Features and Attributes

Table 97. Insilico Medicine Revenue (US$ Million) and Gross Margin (2020-2025)

Table 98. Insilico Medicine Recent Developments

Table 99. Schrödinger Corporation Information

Table 100. Schrödinger Description and Major Businesses

Table 101. Schrödinger Product Features and Attributes

Table 102. Schrödinger Revenue (US$ Million) and Gross Margin (2020-2025)

Table 103. Schrödinger Recent Developments

Table 104. BenevolentAI Corporation Information

Table 105. BenevolentAI Description and Major Businesses

Table 106. BenevolentAI Product Features and Attributes

Table 107. BenevolentAI Revenue (US$ Million) and Gross Margin (2020-2025)

Table 108. BenevolentAI Recent Developments

Table 109. Evotec Corporation Information

Table 110. Evotec Description and Major Businesses

Table 111. Evotec Product Features and Attributes

Table 112. Evotec Revenue (US$ Million) and Gross Margin (2020-2025)

Table 113. Evotec Recent Developments

Table 114. PeptiFinder Corporation Information

Table 115. PeptiFinder Description and Major Businesses

Table 116. PeptiFinder Product Features and Attributes

Table 117. PeptiFinder Revenue (US$ Million) and Gross Margin (2020-2025)

Table 118. PeptiFinder Recent Developments

Table 119. Xtalpi Corporation Information

Table 120. Xtalpi Description and Major Businesses

Table 121. Xtalpi Product Features and Attributes

Table 122. Xtalpi Revenue (US$ Million) and Gross Margin (2020-2025)

Table 123. Xtalpi Recent Developments

Table 124. Sun Novo Corporation Information

Table 125. Sun Novo Description and Major Businesses

Table 126. Sun Novo Product Features and Attributes

Table 127. Sun Novo Revenue (US$ Million) and Gross Margin (2020-2025)

Table 128. Sun Novo Recent Developments

Table 129. Zonsen Peplib Biotech Corporation Information

Table 130. Zonsen Peplib Biotech Description and Major Businesses

Table 131. Zonsen Peplib Biotech Product Features and Attributes

Table 132. Zonsen Peplib Biotech Revenue (US$ Million) and Gross Margin (2020-2025)

Table 133. Zonsen Peplib Biotech Recent Developments

Table 134. Tide Tron Biotech Corporation Information

Table 135. Tide Tron Biotech Description and Major Businesses

Table 136. Tide Tron Biotech Product Features and Attributes

Table 137. Tide Tron Biotech Revenue (US$ Million) and Gross Margin (2020-2025)

Table 138. Tide Tron Biotech Recent Developments

Table 139. Raw Materials Key Suppliers

Table 140. Distributors List

Table 141. Market Trends and Market Evolution

Table 142. Market Drivers and Opportunities

Table 143. Market Challenges, Risks, and Restraints

Table 144. Research Programs/Design for This Report

Table 145. Key Data Information from Secondary Sources

Table 146. Key Data Information from Primary Sources

List of Figures

Figure 1. AI-driven Peptide Drug Discovery Platform Product Picture

Figure 2. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Design and Generation Platform Product Picture

Figure 4. Screening and Optimization Platform Product Picture

Figure 5. Data-driven Platform Product Picture

Figure 6. Others Product Picture

Figure 7. Global AI-driven Peptide Drug Discovery Platform Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 8. Scientific Research

Figure 9. Pharmaceuticals

Figure 10. AI-driven Peptide Drug Discovery Platform Report Years Considered

Figure 11. Global AI-driven Peptide Drug Discovery Platform Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 13. Global AI-driven Peptide Drug Discovery Platform Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 14. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Region (2020-2031)

Figure 15. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share Ranking (2024)

Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 17. Design and Generation Platform Revenue Market Share by Player in 2024

Figure 18. Screening and Optimization Platform Revenue Market Share by Player in 2024

Figure 19. Data-driven Platform Revenue Market Share by Player in 2024

Figure 20. Others Revenue Market Share by Player in 2024

Figure 21. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Type (2020-2031)

Figure 22. Global AI-driven Peptide Drug Discovery Platform Revenue Market Share by Application (2020-2031)

Figure 23. North America AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)

Figure 24. North America Top 5 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024

Figure 25. North America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020 - 2031)

Figure 26. North America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)

Figure 27. US AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 28. Canada AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 29. Mexico AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 30. Europe AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)

Figure 31. Europe Top 5 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024

Figure 32. Europe AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020-2031)

Figure 33. Europe AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)

Figure 34. Germany AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 35. France AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 36. U.K. AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 37. Italy AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 38. Russia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)

Figure 40. Asia-Pacific Top 8 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024

Figure 41. Asia-Pacific AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020-2031)

Figure 42. Asia-Pacific AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)

Figure 43. Indonesia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 44. Japan AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 45. South Korea AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 46. Australia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 47. India AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 48. Indonesia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 49. Vietnam AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 50. Malaysia AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 51. Philippines AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 52. Singapore AI-driven Peptide Drug Discovery Platform Revenue (2020-2031) & (US$ Million)

Figure 53. Central and South America AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)

Figure 54. Central and South America Top 5 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024

Figure 55. Central and South America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020-2031)

Figure 56. Central and South America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)

Figure 57. Brazil AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)

Figure 58. Argentina AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)

Figure 59. Middle East and Africa AI-driven Peptide Drug Discovery Platform Revenue YoY (2020-2031) & (US$ Million)

Figure 60. Middle East and Africa Top 5 Players AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) in 2024

Figure 61. South America AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Type (2020-2031)

Figure 62. Middle East and Africa AI-driven Peptide Drug Discovery Platform Revenue (US$ Million) by Application (2020-2031)

Figure 63. GCC Countries AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)

Figure 64. Israel AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)

Figure 65. Egypt AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)

Figure 66. South Africa AI-driven Peptide Drug Discovery Platform Revenue (2020-2025) & (US$ Million)

Figure 67. AI-driven Peptide Drug Discovery Platform Industry Chain Mapping

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-26S19632

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Ifosfamide for Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-30A19656

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Montelukast Sodium Tablet Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-27H17544

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Grade Omega-3 Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-10A20150

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global AI-driven Peptide Drug Discovery Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-28G19752

Global AI-driven Peptide Drug Discovery Platform Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

AI-driven Peptide Drug Discovery Platform Market Size

AI-driven Peptide Drug Discovery Platform Market

Report Includes:

Scope of AI-driven Peptide Drug Discovery Platform Market Report

Chapter Outline

FAQ for this report

How fast is AI-driven Peptide Drug Discovery Platform Market growing?

What is the AI-driven Peptide Drug Discovery Platform Market size in 2031?

Who are the main players in the AI-driven Peptide Drug Discovery Platform Market report?

What are the Application segmentation covered in the AI-driven Peptide Drug Discovery Platform Market report?

What are the Type segmentation covered in the AI-driven Peptide Drug Discovery Platform Market report?

FEATURED COMPANIES

RELATED REPORTS